BioSpecifics Technologies Corporation (BSTC)
Create an AlertBioSpecifics Technologies Corporation Enterprise Value:
89.14M for June 18, 2013BioSpecifics Technologies Corporation Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 18, 2013 | 89.14M |
| June 17, 2013 | 89.65M |
| June 14, 2013 | 89.08M |
| June 13, 2013 | 88.19M |
| June 12, 2013 | 87.68M |
| June 11, 2013 | 88.95M |
| June 10, 2013 | 90.67M |
| June 7, 2013 | 88.95M |
| June 6, 2013 | 89.59M |
| June 5, 2013 | 88.82M |
| June 4, 2013 | 90.60M |
| June 3, 2013 | 95.17M |
| May 31, 2013 | 88.63M |
| May 30, 2013 | 88.19M |
| May 29, 2013 | 88.51M |
| May 28, 2013 | 91.93M |
| May 24, 2013 | 88.00M |
| May 23, 2013 | 88.51M |
| May 22, 2013 | 86.92M |
| May 21, 2013 | 88.00M |
| May 20, 2013 | 87.17M |
| May 17, 2013 | 88.63M |
| May 16, 2013 | 87.56M |
| May 15, 2013 | 86.98M |
| May 14, 2013 | 86.29M |
| May 13, 2013 | 84.57M |
| May 10, 2013 | 85.21M |
| May 9, 2013 | 84.76M |
| May 8, 2013 | 84.06M |
| May 7, 2013 | 85.27M |
| May 6, 2013 | 86.41M |
| May 3, 2013 | 86.36M |
| May 2, 2013 | 87.25M |
| May 1, 2013 | 85.66M |
| April 30, 2013 | 88.59M |
| April 29, 2013 | 88.46M |
| April 26, 2013 | 95.76M |
| April 25, 2013 | 96.02M |
| April 24, 2013 | 96.08M |
| April 23, 2013 | 96.91M |
| April 22, 2013 | 91.95M |
| April 19, 2013 | 91.32M |
| April 18, 2013 | 87.70M |
| April 17, 2013 | 88.52M |
| April 16, 2013 | 93.09M |
| April 15, 2013 | 90.36M |
| April 12, 2013 | 97.60M |
| April 11, 2013 | 96.59M |
| April 10, 2013 | 96.52M |
| April 9, 2013 | 94.37M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
BSTC Enterprise Value Benchmarks
| Companies | |
|---|---|
| Auxilium Pharmaceuticals | 377.79M |
| Actelion | 6.711B |
| ARCA biopharma | 0.668M |
BSTC Enterprise Value Rankings
| Overall |
69th percentile 5127 of 16770 |
| Sector |
66th percentile 468 of 1408 in Healthcare |
| Industry |
66th percentile 151 of 453 in Biotechnology |
BSTC Enterprise Value Range, Past 5 Years
| Minimum | 64.81M | Oct 29 2008 |
| Maximum | 196.57M | Oct 13 2009 |
| Average | 123.12M |
